TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)
CUSIP: 89455T109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, $0.001 par value
- Shares outstanding
- 63,703,704
- Total 13F shares
- 39,705,068
- Share change
- -1,530,481
- Total reported value
- $264,072,594
- Put/Call ratio
- 96%
- Price per share
- $6.65
- Number of holders
- 126
- Value change
- -$75,189,680
- Number of buys
- 90
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89455T109:
Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| John R. Treace |
3/4/5
|
Director |
—
class O/S missing
|
2,231,606
|
$59,159,875 | — | 09 May 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.8%
|
4,303,399
|
$56,159,356 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
3,700,196
|
$48,287,557 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
5.2%
|
3,292,068
|
$42,961,496 | — | 31 Mar 2024 | |
| Thomas E. Timbie |
3/4/5
|
Director |
—
class O/S missing
|
1,513,064
|
$40,111,326 | — | 15 Mar 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.8%
|
2,400,000
|
$31,320,000 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.7%
|
2,329,511
|
$30,400,119 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.6%
|
2,304,954
|
$30,079,650 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.2%
|
2,041,938
|
$26,647,291 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
2.9%
|
1,854,916
|
$23,186,450 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
2.5%
|
1,561,893
|
$20,382,704 | — | 31 Mar 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
2.2%
|
1,384,129
|
$18,063,000 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
2.1%
|
1,345,648
|
$17,560,706 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2%
|
1,264,264
|
$16,498,645 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,250,608
|
$16,320,434 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1.9%
|
1,229,128
|
$16,040,120 | — | 31 Mar 2024 | |
| Joe W. Ferguson |
3/4/5
|
SVP, Research & Development |
—
mixed-class rows
|
754,325
mixed-class rows
|
$13,396,325 | — | 06 Oct 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
987,727
|
$12,891,581 | — | 31 Mar 2024 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
1.2%
|
769,808
|
$10,045,994 | — | 31 Mar 2024 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
1.1%
|
677,733
|
$8,844,416 | — | 31 Mar 2024 | |
| Jaime A. Frias |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
337,008
mixed-class rows
|
$7,322,274 | — | 08 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.71%
|
454,945
|
$5,937,032 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
397,795
|
$5,191,225 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.59%
|
377,872
|
$4,931,230 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.58%
|
368,000
|
$4,802,400 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.58%
|
367,029
|
$4,789,728 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.57%
|
360,000
|
$4,698,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
358,350
|
$4,676,468 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.44%
|
279,118
|
$3,642,489 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.43%
|
276,439
|
$3,607,529 | — | 31 Mar 2024 | |
| FORMULA GROWTH LTD |
13F
|
Company |
0.42%
|
268,069
|
$3,498,300 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.4%
|
255,997
|
$3,340,761 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
243,305
|
$3,175,130 | — | 31 Mar 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.38%
|
241,062
|
$3,145,859 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
177,400
|
$2,315,000 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
174,672
|
$2,279,470 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.27%
|
172,050
|
$2,245,252 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.25%
|
161,446
|
$2,106,870 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.25%
|
156,795
|
$2,046,175 | — | 31 Mar 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.23%
|
143,359
|
$1,870,835 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
142,692
|
$1,862,131 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.21%
|
135,913
|
$1,773,665 | — | 31 Mar 2024 | |
| Archon Capital Management LLC |
13F
|
Company |
0.2%
|
130,097
|
$1,697,766 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.2%
|
127,669
|
$1,666,080 | — | 31 Mar 2024 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.2%
|
126,221
|
$1,647,184 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.19%
|
122,160
|
$1,594,188 | — | 31 Mar 2024 | |
| Divisadero Street Capital Management, LP |
13F
|
Company |
0.18%
|
114,400
|
$1,492,920 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
112,703
|
$1,470,775 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
97,958
|
$1,278,352 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.15%
|
95,008
|
$1,239,854 | — | 31 Mar 2024 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2024
As of 30 Jun 2024,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,705,068 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, Soleus Capital Management, L.P., DEUTSCHE BANK AG\, CIBC Private Wealth Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
126
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
129
Q2 2024 holders
126
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.